Long-term followup of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux

被引:219
作者
Läckgren, G [1 ]
Wåhlin, N [1 ]
Sköldenberg, E [1 ]
Stenberg, A [1 ]
机构
[1] Uppsala Univ, Childrens Hosp, Urol Sect, S-75238 Uppsala, Sweden
关键词
ureter; hyaluronic acid; vesico-ureteral reflux; endoscopy; child;
D O I
10.1016/S0022-5347(05)65713-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Dextranomer/hyaluronic acid copolymer is a novel substance that has favorable properties for endoscopic treatment of vesicoureteral reflux. We assess the long-term efficacy and safety of this treatment of children. Materials and Methods: Children 1 to 15 years old with grade III or greater vesicoureteral reflux were eligible for enrollment in our study. All patients received endoscopic treatment with dextranomer/hyaluronic acid copolymer and were scheduled to have a voiding cystourethrogram 3 and 12 months after implantation. Children with reflux grade III or greater after treatment received up to 2 more implantations, and those with persistent reflux were referred for open surgery. In some cases long-term clinical followup was accompanied by a late voiding cystourethrogram. Results: A total of 228 patients received endoscopic treatment. The efficacy population was comprised of 221 children, including 67 who received 2 and 8 who received 3 implantations. Endoscopic treatment was performed without complications in all cases. Patients were followed clinically for 2 to 7.5 years (mean 5). On the last voiding cystourethrogram 68% of patients had a positive response (grade I or less) and 81% had no dilating reflux. The corresponding results for treated ureters were 75% and 85%, respectively. Only 27 (12%) patients were referred for open surgery. A late voiding cystourethrogram was performed in 49 patients 2 to 5 years after treatment. Of the ureters free of reflux (grade 0) 3 to 12 months after treatment 96% remained free of dilating reflux. Adverse events occurred in association with implantation in only 2% of patients, although urinary tract infection subsequently developed in 8%. Conclusions: Endoscopic treatment with dextranomer/hyaluronic acid copolymer was effective and well tolerated in children with vesicoureteral reflux. Long-term followup indicated that there was no deterioration in patients responding positively to treatment.
引用
收藏
页码:1887 / 1892
页数:6
相关论文
共 24 条
[1]   LONG-TERM FOLLOW-UP OF INFANTS WITH GROSS VESICOURETERAL REFLUX [J].
BAILEY, RR ;
LYNN, KL ;
SMITH, AH .
JOURNAL OF UROLOGY, 1992, 148 (05) :1709-1711
[2]   END-STAGE REFLUX NEPHROPATHY [J].
BAILEY, RR ;
LYNN, KL ;
ROBSON, RA .
RENAL FAILURE, 1994, 16 (01) :27-35
[3]   Antibacterial prophylaxis in children with urinary tract infection [J].
Bollgren, I .
ACTA PAEDIATRICA, 1999, 88 :48-52
[4]   ASSOCIATION BETWEEN BOVINE COLLAGEN DERMAL IMPLANTS AND A DERMATOMYOSITIS OR A POLYMYOSITIS-LIKE SYNDROME [J].
CUKIER, J ;
BEAUCHAMP, RA ;
SPINDLER, JS ;
SPINDLER, S ;
LORENZO, C ;
TRENTHAM, DE .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (12) :920-928
[5]  
DEWAN A, 1995, PEDIATR SURG INT, V10, P129
[6]   Skin migration following periurethral polytetrafluoroethylene injection for urinary incontinence [J].
Dewan, PA ;
Fraundorfer, M .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1996, 66 (01) :57-59
[7]   Failure of subureteral bovine collagen injection for the endoscopic treatment of primary vesicoureteral reflux in long-term follow-up [J].
Haferkamp, A ;
Contractor, H ;
Möhring, K ;
Staehler, G ;
Dörsam, J .
UROLOGY, 2000, 55 (05) :759-763
[8]   Urinary tract infection, day wetting and other voiding symptoms in seven- to eight-year-old Danish children [J].
Hansen, A ;
Hansen, B ;
Dahm, TL .
ACTA PAEDIATRICA, 1997, 86 (12) :1345-1349
[9]  
Hatanaka Shingo, 1993, In Vivo (Attiki), V7, P111
[10]   PARTICULATE SILICONE FOR USE IN PERIURETHRAL INJECTIONS - LOCAL TISSUE EFFECTS AND SEARCH FOR MIGRATION [J].
HENLY, DR ;
BARRETT, DM ;
WEILAND, TL ;
OCONNOR, MK ;
MALIZIA, AA ;
WEIN, AJ .
JOURNAL OF UROLOGY, 1995, 153 (06) :2039-2043